Home/Spotlight on our Specialist reviews

Spotlight on our Specialist reviews

Our specialist reviews provide clear, evidence-based and up-to-date information of clinical problems or conditions with a particular focus on pathophysiology, mechanisms of disease and drug pharmacology. All of our specialist reviews are externally peer reviewed. Browse all specialist reviews

Meet our series advisors

Our international board of series advisers works with our team to develop BMJ Medicine‘s specialist reviews section. They provide expert input to help us identify the most critical issues within a wide range of specialties to provide BMJ Medicine‘s audience with timely, topical clinical content to help shape practice and future research. Specialist reviews by BMJ Medicine quote from Editor in Chief Sophie Cook

Read our latest reviews

BMJ Medicine is continuously publishing specialist reviews. Browse all reviews now!
Pathophysiology and new advances in pulmonary hypertension Simon Bousseau et al. This review focuses on this type of pulmonary hypertension. The review highlights key pathophysiological concepts and emerging therapeutic directions, targeting inflammation, cellular metabolism, genetics and epigenetics, sex hormone signalling, bone morphogenetic protein signalling, and inhibition of tyrosine kinase receptors.
Sleep apnoea circulating biomarkers diagram
Role of precision medicine in obstructive sleep apnoea Yu Liu et al. This narrative review summarises the current knowledge of precision medicine in obstructive sleep apnoea, particularly the role of symptom clusters, polysomnogram phenotypes, physiological endotypes, and circulating biomarkers in defining subtypes.
Management of gestational throphoblastic disease
Advances in the diagnosis and early management of gestational trophoblastic disease Carolyne M Joyce et al. This review looks at advances in the diagnosis and early management of gestational trophoblastic disease and highlights updates to disease classification and clinical guidelines. Use of molecular genotyping for improved diagnostic accuracy and risk stratification is reviewed and future biomarkers for the earlier detection of malignancy are considered.